Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary Report

Transplantation. 2022 Sep 1;106(9):e426-e428. doi: 10.1097/TP.0000000000004240. Epub 2022 Jun 14.

Authors

Sarah Frey¹, Jessica M Ruck¹, Jennifer L Alejo¹, Lindsay Barker², Joby Matthew², William A Werbel³, Robin K Avery⁴, Dorry L Segev^{1

3}, Pali D Shah²

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
² Division of Pulmonology and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Surgery, New York University, New York, NY.
⁴ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral
Antimetabolites
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Immunosuppressive Agents / adverse effects
Lung
SARS-CoV-2
Transplant Recipients

Substances

Antibodies, Viral
Antimetabolites
COVID-19 Vaccines
Immunosuppressive Agents

Grants and funding